Rapid Zika Detection Test Uses Smartphone Technology
By LabMedica International staff writers Posted on 10 Jul 2018 |
Image: Motion-based immunological detection of Zika virus using Platinum (Pt)-Nanomotors and a cell phone (Photo courtesy of Brigham and Women\'s Hospital).
The Zika virus, which continues to cause microcephaly and other neurological complications in infants whose mothers were infected during pregnancy, remains a public health concern.
Traditional virus diagnostics rely on detecting antibodies in a person's bloodstream that target Zika. However, many closely related viruses, including dengue, can elicit similar antibodies, leading to a high false positive rate for such tests.
Investigators from Brigham and Women's Hospital (Boston, MA; USA) and their colleagues have developed a new way to rapidly and accurately diagnose Zika using mobile health technologies that could potentially be deployed in resource-limited settings. The team used nanotechnology and developed tiny platinum nanomotors that target Zika as well as microbeads that bind the virus. When both components are added to a sample containing Zika, they form a three-dimensional complex that moves in the presence of hydrogen peroxide (H2O2). This movement can be detected using a smartphone hooked up to an optical device that costs USD 5.
The presence of virus in a testing sample results in the accumulation of platinum (Pt)-nanomotors on the surface of beads, causing their motion in H2O2 solution. Then the virus concentration is detected in correlation with the change in beads motion. The developed nanomotor-based bead-motion cell phone (NBC) system was capable of detecting Zika virus (ZIKV) in samples with virus concentrations as low as 1 particle/μL. The NBC system allowed a highly specific detection of ZIKV in the presence of the closely related dengue virus and other neurotropic viruses, such as herpes simplex virus type 1 and human cytomegalovirus.
Mohamed Shehata Draz, PhD, a postdoctoral fellow and the first author of the study, said, “The NBC system has the potential to be used at the point of care for disease detection in both developed and developing countries. This is an important way to eliminate the social stress related to Zika virus infection and health problems specifically related to newborns.” The study was published online on May 16, 2018, in the journal ACS Nano.
Related Links:
Brigham and Women's Hospital
Traditional virus diagnostics rely on detecting antibodies in a person's bloodstream that target Zika. However, many closely related viruses, including dengue, can elicit similar antibodies, leading to a high false positive rate for such tests.
Investigators from Brigham and Women's Hospital (Boston, MA; USA) and their colleagues have developed a new way to rapidly and accurately diagnose Zika using mobile health technologies that could potentially be deployed in resource-limited settings. The team used nanotechnology and developed tiny platinum nanomotors that target Zika as well as microbeads that bind the virus. When both components are added to a sample containing Zika, they form a three-dimensional complex that moves in the presence of hydrogen peroxide (H2O2). This movement can be detected using a smartphone hooked up to an optical device that costs USD 5.
The presence of virus in a testing sample results in the accumulation of platinum (Pt)-nanomotors on the surface of beads, causing their motion in H2O2 solution. Then the virus concentration is detected in correlation with the change in beads motion. The developed nanomotor-based bead-motion cell phone (NBC) system was capable of detecting Zika virus (ZIKV) in samples with virus concentrations as low as 1 particle/μL. The NBC system allowed a highly specific detection of ZIKV in the presence of the closely related dengue virus and other neurotropic viruses, such as herpes simplex virus type 1 and human cytomegalovirus.
Mohamed Shehata Draz, PhD, a postdoctoral fellow and the first author of the study, said, “The NBC system has the potential to be used at the point of care for disease detection in both developed and developing countries. This is an important way to eliminate the social stress related to Zika virus infection and health problems specifically related to newborns.” The study was published online on May 16, 2018, in the journal ACS Nano.
Related Links:
Brigham and Women's Hospital
Latest Microbiology News
- Integrated Solution Ushers New Era of Automated Tuberculosis Testing
- Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia